Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

Background: Response Evaluation Criteria in Solid Tumors (RECIST) has been widely utilized to evaluate new therapeutic strategies in cancer. However, RECIST fails to assess the heterogeneity of response in highly active therapies. Depth of response (DepOR), defined as the maximum percentage change i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-Tao, Zhang, Kai, Li, Cheng-Cheng, Hu, Xing-Sheng, Jiang, Jun, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Xing, Pu-Yuan, Yang, Sheng, Zhang, Xin, Wang, Guo-Qiang, Cai, Shang-Li, Shi, Yuan-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775600/
https://www.ncbi.nlm.nih.gov/pubmed/31602263
http://dx.doi.org/10.7150/jca.33450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775600/
https://www.ncbi.nlm.nih.gov/pubmed/31602263
http://dx.doi.org/10.7150/jca.33450

Ejemplares similares